Vericel Corporation
VCELBiotechnology
$42.91+4.43%As of Oct 29vs prior close
- Market cap
- $2.2B
- P/E (TTM)
- 90.7×
- From 52W high
- −11.18%
- EPS (LTM)
- $0.48
- Revenue (LTM)
- $306.3M
- Net margin
- 7.91%
Nomior Score
80
Steady ProfileTop 2% of the scored universe
Growth79
Quality76
Value60
Momentum57
Resilience69
Growth
+19.79%revenue a year over 9 fiscal years
YE16 $54.4MLTM $306.3M
Connections
Revenue to profitQ2 YE26
3% of revenue became net profit, up 4 pts on a year.
Who owns it
2funds, 1 tracked portfolio